Abstract

e15635Background: High peripheral blood NLR is a poor prognostic marker in cancer patients. We investigated the relationship between NLR and measured IRs in patients with chemo-naive aCRC and the m...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P6-06-12: Prognostic significance of pretreatment neutrophil/-lymphocyte ratio in breast cancer: A meta-analysis
A Ocana ... M Al-Mubarak
Cancer Research | VOL. 73
A Ocana, et. al.A Ocana ... M Al-Mubarak
15 Dec 2013
Abstract 4469: Impact of peripheral blood neutrophil lymphocyte ratio on response and survival in various malignancies treated with immunotherapy
Rajshri Ashwath ... Nitin Yashas Murthy
Cancer Research | VOL. 80
Rajshri Ashwath, et. al.Rajshri Ashwath ... Nitin Yashas Murthy
13 Aug 2020
Predicting value of dynamic alteration of blood neutrophil/lymphocyte ratio on recurrence-free survival in patients with advanced colon cancer after operation and chemotherapy
Pei-Ping Li ... Jian Li
Chinese Journal of Gastrointestinal Surgery | VOL. 15
Pei-Ping Li, et. al.Pei-Ping Li ... Jian Li
01 Nov 2012
Abstract 1824: Predictive value of neutrophil-lymphocyte ratio for the efficacy of preoperative chemotherapy in triple-negative breast cancer
Tsutomu Takashima ... Satoru Noda
Cancer Research | VOL. 75
Tsutomu Takashima, et. al.Tsutomu Takashima ... Satoru Noda
01 Aug 2015
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers